A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies.
Phase of Trial: Phase I
Latest Information Update: 18 May 2017
At a glance
- Drugs Rigosertib (Primary)
- Indications B cell lymphoma; Chronic lymphocytic leukaemia; Hairy cell leukaemia; Lymphoma; Mantle-cell lymphoma; Multiple myeloma; Waldenstrom's macroglobulinaemia
- Focus Adverse reactions